Gene expression profile of angiogenic factors in pulmonary arteries in COPD: Relationship with vascular remodeling

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 310, Issue 7, 2016, Pages L583-L592

  García Lucio, Jéssica ^a   Argemi, Gemma ^a   Tura Ceide, Olga ^a,b   Diez, Marta ^a   Paul, Tanja ^a   Bonjoch, Cristina ^a   Coll Bonfill, Nuria ^a   Blanco, Isabel ^a,b   Barberá, Joan A ^a,b   Musri, Melina M ^a   Peinado, Victor I ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Angiopoietin; COPD; Gene expression profile; Pulmonary artery; Vascular remodeling

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; BETA CATENIN; GELATINASE A; GROWTH FACTOR; RNA; VASCULOTROPIN; ANGPT2 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; TRANSCRIPTOME;

ADULT; AGED; ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG LOBECTOMY; LUNG PARENCHYMA; LUNG RESECTION; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR REMODELING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RNA EXTRACTION; SMOKING; TISSUE SECTION; UNIVARIATE ANALYSIS; VASCULAR SMOOTH MUSCLE CELL; GENETICS; INTIMA; LUNG; METABOLISM; PATHOPHYSIOLOGY; VASCULAR REMODELING; VASCULARIZATION;

AGED; ANGIOPOIETIN-2; HUMANS; LUNG; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSCRIPTOME; TUNICA INTIMA; VASCULAR REMODELING;

EID: 84984619750     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00261.2015     Document Type: Article

References (38)

1. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21: 347-360, 2003.
2. Ardite E, Peinado VI, Rabinovich RA, Fernandez-Checa JC, Roca J, Barbera JA. Systemic effects of cigarette smoke exposure in the guinea pig. Respir Med 100: 1186-1194, 2006.
3. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21: 892-905, 2003.
4. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56: 515-548, 2004.
5. Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sanchez F, Gea J, Barbera JA. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 182: 477-488, 2010.
6. Bedel A, Negre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, Salvayre R, Maupas-Schwalm F. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res 103: 694-701, 2008.
7. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598, 1998.
8. Bertolino P, Deckers M, Lebrin F, ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 128: 585S-590S, 2005.
9. Calvi C, Dentelli P, Pagano M, Rosso A, Pegoraro M, Giunti S, Garbarino G, Camussi G, Pegoraro L, Brizzi MF. Angiopoietin 2 induces cell cycle arrest in endothelial cells: a possible mechanism involved in advanced plaque neovascularization. Arterioscler Thromb Vasc Biol 24: 511-518, 2004.
10. Cao Y, Sonveaux P, Liu S, Zhao Y, Mi J, Clary BM, Li CY, Kontos CD, Dewhirst MW. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res 67: 3835-3844, 2007.
11. Carmeliet P. Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
12. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol 43: 423-428, 2004.
13. Christman MA, Goetz DJ, Dickerson E, McCall KD, Lewis CJ, Benencia F, Silver MJ, Kohn LD, Malgor R. Wnt5a is expressed in murine and human atherosclerotic lesions. Am J Physiol Heart Circ Physiol 294: H2864-H2870, 2008.
14. Du L, Sullivan CC, Chu D, Cho AJ, Kido M, Wolf PL, Yuan JX, Deutsch R, Jamieson SW, Thistlethwaite PA. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 348: 500-509, 2003.
15. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14: 25-36, 2008.
16. Giuliano JS Jr, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS. Admission angiopoietin levels in children with septic shock. Shock 28: 650-654, 2007.
17. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 87: 69-98, 2007.
18. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 277: 48-50, 1997.
19. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580, 2004.
20. Hughes SE. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. Cardiovasc Res 32: 557-569, 1996.
21. Jain RK. Molecular regulation of vessel maturation. Nat Med 9: 685-693, 2003.
22. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 110: 2355-2360, 2004.
23. Link A, Poss J, Rbah R, Barth C, Feth L, Selejan S, Bohm M. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. Eur Heart J 34: 1651-1662, 2013.
24. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997.
25. Mofarrahi M, Sigala I, Vassilokopoulos T, Harel S, Guo Y, Debigare R, Maltais F, Hussain SN. Angiogenesis-related factors in skeletal muscles of COPD patients: roles of angiopoietin-2. J Appl Physiol (1985) 114: 1309-1318, 2013.
26. Murayama T, Asahara T. Bone marrow-derived endothelial progenitor cells for vascular regeneration. Curr Opin Mol Ther 4: 395-402, 2002.
27. Peinado VI, Ramirez J, Roca J, Rodriguez-Roisin R, Barbera JA. Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 34: 257-263, 2006.
28. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, Tuder RM. Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 170: 1340-1348, 2004.
29. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285, 2005.
30. Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barbera JA. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 19: 632-638, 2002.
31. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 118: 771-780, 2005.
32. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003.
33. Smyth GK, Yang YH, Speed T. Statistical issues in cDNA microarray data analysis. Methods Mol Biol 224: 111-136, 2003.
34. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514, 1999.
35. Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A 99: 8219-8224, 2002.
36. Wang X, Studzinski GP. Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3. J Cell Physiol 198: 333-342, 2004.
37. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
38. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29: 2011-2022, 2009.